Mark E. Hensley - May 6, 2025 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Chief Operating Officer
Signature
/s/Kathryn Lester Attorney-in-fact for Mark E. Hensley
Stock symbol
HRTX
Transactions as of
May 6, 2025
Transactions value $
$0
Form type
4
Date filed
5/7/2025, 12:20 PM
Previous filing
Apr 29, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hensley Mark Earl Chief Operating Officer 100 REGENCY FOREST DRIVE, SUITE 300, CARY /s/Kathryn Lester Attorney-in-fact for Mark E. Hensley 2025-05-07 0002065816

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Restricted Stock Units Award $0 +500K $0.00 500K May 6, 2025 Common Stock 500K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installmens thereafter.